UK Medtechs Say Conditional Reimbursement Will Open Doors To Innovation Adoption
As the UK NHS Medtech Funding Mandate finally becomes live, the medtech industry is pressing the case for another mechanism that will allow more innovation onto the UK market.
You may also be interested in...
Evolving health care demands, digital innovation and the need to work within tighter budgets have prompted the UK’s NICE to reset its strategy for the coming five years.
The Medtech Mandate, a scheme that seeks to better match NICE guidance with adoption and use of medtech innovations in the UK, is preparing for launch in April.
Reaching deep and being resourceful were the in-demand attributes that medtech industry leaders brought to bear when the COVID-19 pandemic stretched health care providers almost to breaking point.